Viewing Study NCT02648269


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-04 @ 3:30 AM
Study NCT ID: NCT02648269
Status: COMPLETED
Last Update Posted: 2017-01-30
First Post: 2016-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
Sponsor: Selecta Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module